APTO - Aptose Biosciences' (APTO) CEO William Rice on Q3 2020 Results - Earnings Call Transcript

Aptose Biosciences Inc. (APTO) Q3 2020 Earnings Conference Call November 10, 2020 5:00 PM ET Company Participants Susan Pietropaolo – Communications Representative William Rice – Chairman, President and Chief Executive Officer Gregory Chow – Executive Vice President and Chief Financial Officer Rafael Bejar – Senior Vice President and Chief Medical Officer Conference Call Participants Gregory Renza – RBC Capital Markets John Newman – Canaccord Emily Bodnar – Cantor Fitzgerald Joe Pantginis – H.C. Wainwright Matt Biegler – Oppenheimer Matthew Cross – Alliance Global Partners Presentation Operator Good afternoon. My name is Chris, and I will be your conference operator today. I’d like to welcome everyone to the Aptos Biosciences’ Conference Call for the Third Quarter Ended September 30, 2020. At this time, all participants are in a listen-only mode. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] As a reminder, this conference call may be recorded.

For further details see:

Aptose Biosciences' (APTO) CEO William Rice on Q3 2020 Results - Earnings Call Transcript